Their expectations for COVID were not met but other things are being done there with VIP. Out some there @3.35 this am and bought here @.52. Bottom.?... We'll see how well this VIP works for COVID and Lung issues with expected good DATA soon from apparently full enrollment in the IV / (EUA?) Trials. "Expanded Access intermediate size population" is that designation NOW which was "Expanded Access personal use" ('EUA') before the Oct 22 CT.gov update. Also combining this makes the PR totals match better. We'll see if that is significant.?. Then IPO with nrx to NYSE for Phase 3.?...GLTA...
Market Data 
Markets 
AI
